- Metabolic Risk/Epidemiology
- Role of Fenofibrate Use in Dyslipidemia and Related Comorbidities in the Asian Population: A Narrative Review
-
Chaicharn Deerochanawong, Sin Gon Kim, Yu-Cheng Chang
-
Diabetes Metab J. 2024;48(2):184-195. Published online January 26, 2024
-
DOI: https://doi.org/10.4093/dmj.2023.0168
-
-
9,156
View
-
697
Download
-
8
Web of Science
-
9
Crossref
-
 Abstract
 PDF Supplementary Material PubReader  ePub
- Hypertriglyceridemia and decreased high-density lipoprotein cholesterol (HDL-C) persist despite statin therapy, contributing to residual atherosclerotic cardiovascular disease (ASCVD) risk. Asian subjects are metabolically more susceptible to hypertriglyceridemia than other ethnicities. Fenofibrate regulates hypertriglyceridemia, raises HDL-C levels, and is a recommended treatment for dyslipidemia. However, data on fenofibrate use across different Asian regions are limited. This narrative review summarizes the efficacy and safety data of fenofibrate in Asian subjects with dyslipidemia and related comorbidities (diabetes, metabolic syndrome, diabetic retinopathy, and diabetic nephropathy). Long-term fenofibrate use resulted in fewer cardiovascular (CV) events and reduced the composite of heart failure hospitalizations or CV mortality in type 2 diabetes mellitus. Fenofibrate plays a significant role in improving irisin resistance and microalbuminuria, inhibiting inflammatory responses, and reducing retinopathy incidence. Fenofibrate plus statin combination significantly reduced composite CV events risk in patients with metabolic syndrome and demonstrated decreased triglyceride and increased HDL-C levels with an acceptable safety profile in those with high CV or ASCVD risk. Nevertheless, care is necessary with fenofibrate use due to possible hepatic and renal toxicities in vulnerable individuals. Long-term trials and real-world studies are needed to confirm the clinical benefits of fenofibrate in the heterogeneous Asian population with dyslipidemia.
-
Citations
Citations to this article as recorded by  - Triterpenoids from ilicis rotundae cortex ameliorate hyperlipidemia by affecting bile acids-hepatointestinal FXR axis
Wei Zeng, Mengjia Sun, Jiamin Cao, Caixin Chen, Shiqin Jiang, Yuanyuan Wang, Weiqun Yang, Zhongxiang Zhao, Jing Jin
Phytomedicine.2025; 139: 156537. CrossRef - Targeting of AMPK/MTOR signaling in the management of atherosclerosis: Outmost leveraging
Hayder M. Al-kuraishy, Ghassan M. Sulaiman, Mayyadah H. Mohsin, Hamdoon A. Mohammed, Retaj A. Dawood, Ali K. Albuhadily, Ali I. Al-Gareeb, Salim Albukhaty, Mosleh M. Abomughaid
International Journal of Biological Macromolecules.2025; 309: 142933. CrossRef - Fenofibrate promotes erucic acid metabolism by peroxisome enzyme EHHADH activation alleviating high-fat diet–induced steatotic liver disease
Ming Jin, Rongmi Zhang, Wenwen Xin, Li Sun, Xue Fan, Qian Lu, Luyong Zhang, Zhenzhou Jiang, Qinwei Yu
Molecular Pharmacology.2025; 107(7): 100047. CrossRef - Fenofibrate ameliorates ocular surface inflammation in diabetic keratopathy
Hassan Mansoor, Isabelle Xin Yu Lee, Chang Liu, Mingyi Yu, Charmaine Jan Li Toh, Victor Wei-Tsu Hsu, Fengyi Liu, Daqian Lu, Thomas Chuen Lam, Hong Chang Tan, Lei Zhou, Yu-Chi Liu
The Ocular Surface.2025; 38: 31. CrossRef - An exploration of molecular signaling in drug reprocessing for Oral Squamous Cell Carcinoma
Ali Nakhaei, Sarah Marzoughi, Sahar Ghoflchi, Hossein Hosseini, Amir R. Afshari, Mohammad Jalili-Nik, Prashant Kesharwani, Amirhossein Sahebkar
European Journal of Medicinal Chemistry.2025; 295: 117816. CrossRef - Fenofibrate to prevent amputation and reduce vascular complications in patients with diabetes: FENO-PREVENT
Eu Jeong Ku, Bongseong Kim, Kyungdo Han, Seung-Hwan Lee, Hyuk-Sang Kwon
Cardiovascular Diabetology.2024;[Epub] CrossRef - The role of DGAT1 and DGAT2 in tumor progression via fatty acid metabolism: A comprehensive review
Leisheng Wang, Shiwei Xu, Mengzhen Zhou, Hao Hu, Jinyou Li
International Journal of Biological Macromolecules.2024; 278: 134835. CrossRef -
An exploratory investigation of lipid-lowering potential of spirulina (
Arthrospira platensis
) targeting apoprotein-E in chronic hyperlipidemic
wistar albino
rats
Anum Nazir, Mahr Un Nisa, Mohamed H. Mahmoud, Ahmed M. El-Gazzar, Eliasse Zongo
Cogent Food & Agriculture.2024;[Epub] CrossRef - Advances in Understanding Diabetic Kidney Disease Progression and the Mechanisms of Acupuncture Intervention
Jinyi Shan, Ziyi Cao, Siming Yu
International Journal of General Medicine.2024; Volume 17: 5593. CrossRef
|
KDA
